Sodium Acetate
Electrolyte Solutions
Sold as InterSol · Natrum Aceticum · H.E.L.P. ACETATE BUFFER…
- Drug class
- Electrolyte Solutions
- Availability
- Prescription and OTC
- Routes
- Intravenous, Oral
- Markets covered
- 3
- Products on record
- 8
- FDA reports (12 mo)
- 28
Overview
Sodium Acetate is an active pharmaceutical ingredient in the Electrolyte Solutions group (B05XA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 4 | April 10, 2026 |
| US United States | FDA | 2 | June 27, 2025 |
| CA Canada | Health Canada | 2 | March 22, 2025 |
GBUnited Kingdom· MHRA
4 products
Uses
Supply of energy, essential fatty acids, amino acids, electrolytes and fluids for parenteral nutrition of patients in states of moderate to severe catabolism when oral or enteral nutrition is impossible, insufficient or contraindicated.
Lipoflex special is indicated in adults, adolescents and children older than two years.
How to take
USUnited States· FDA
2 products
Uses
6B7800S 12x 800 mL Rx only Store at Controlled Room Temperature. Protect from freezing. Avoid excessive heat. Definition of "Controlled Room Temperature": "A temperature maintained thermostatically that encompasses the usual and customary working environment of 20° to 25°C (68° to 77°F); that results in a mean kinetic temperature calculated to be not more than 25°C; and that allows for excursions between 15°C and 30°C (59° and 86°F) that are experienced in pharmacies, hospitals, and warehouses.
Provided the mean kinetic temperature remains in the allowed range, transient spikes up to 40°C are permitted as long as they do not exceed 24 hours ... " Reference: United States Pharmacopeia, General Notices. United States Pharmacopeial Convention, Inc.
12601 Twinbrook Parkway, Rockville, MD. Dispose of waste in appropriate biohazard container or according to local regulatory requirements.
Indications and Usage:
CACanada· Health Canada
2 products
Uses
AND CLINICAL USE ............................................................................................ 3 CONTRAINDICATIONS ............................................................................................................
3 WARNINGS............................................................................................................................ 3 PRECAUTIONS .......................................................................................................................
4 ADVERSE REACTIONS............................................................................................................. 5 OVERDOSAGE ........................................................................................................................
5 DOSAGE AND ADMINISTRATION ............................................................................................ 5 AVAILABILITY OF DOSAGE FORMS .........................................................................................
Drug interactions
Known interactions involving Sodium Acetate. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL035510140 · revised February 21, 2025
- [2]FDA DailyMed · 17dec820-1b57-4a… · revised June 27, 2025 [PDF]
- [3]Health Canada (DPD) · 02139529 · revised March 22, 2025
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.